Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$0.93
+1.2%
$4.79
$4.86
$37.50
$5.60M1.55467,323 shs28,370 shs
IRIDEX Co. stock logo
IRIX
IRIDEX
$0.98
-1.0%
$1.03
$0.78
$2.58
$16.45M0.6947,342 shs134,601 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.23
+1.7%
$1.69
$0.53
$4.49
$21.13M4.671.24 million shs30,782 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$2.00
-2.9%
$2.18
$1.72
$5.35
$6.42M0.8717,958 shs30,980 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nuwellis, Inc. stock logo
CHFS
Nuwellis
+1.89%-4.48%+3.91%-29.46%+252.69%
IRIDEX Co. stock logo
IRIX
IRIDEX
-1.03%-2.97%-19.67%-34.88%-62.16%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+1.65%-3.15%-29.71%-57.14%+6.96%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-2.91%-13.42%+1.57%-8.68%-55.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/AN/AN/AN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
0.7879 of 5 stars
0.04.00.00.02.41.70.0
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
2.7824 of 5 stars
3.55.00.00.01.13.30.0
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.1524 of 5 stars
3.55.00.00.01.81.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.00
N/AN/AN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
0.00
N/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00306.50% Upside
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.00
Buy$5.00150.00% Upside

Current Analyst Ratings Breakdown

Latest CHFS, IRIX, NXL, and STRR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $5.00
3/24/2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$5.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$5.51M1.02N/AN/A$12.79 per share0.07
IRIDEX Co. stock logo
IRIX
IRIDEX
$48.80M0.34N/AN/A$0.59 per share1.66
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$131.07K161.21N/AN/A$0.43 per share2.86
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$57.17M0.11$0.33 per share6.11$14.63 per share0.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nuwellis, Inc. stock logo
CHFS
Nuwellis
-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/A
IRIDEX Co. stock logo
IRIX
IRIDEX
-$9.57M-$0.43N/AN/A-22.79%-192.95%-33.97%8/6/2025 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65M-$0.83N/AN/A-3,407.98%-187.59%-167.21%N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$25.13M-$3.43N/AN/AN/A-12.41%-8.72%-4.62%8/12/2025 (Estimated)

Latest CHFS, IRIX, NXL, and STRR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million
5/13/2025Q1 2025
IRIDEX Co. stock logo
IRIX
IRIDEX
-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
3/27/2025Q4 2024
IRIDEX Co. stock logo
IRIX
IRIDEX
-$0.05-$0.05N/A-$0.05$12.80 million$12.70 million
3/20/2025Q4 2024
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 million
3/14/2025Q4 2024
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A-$0.28N/A-$0.28N/A$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/A
IRIDEX Co. stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/A
6.87
5.97
IRIDEX Co. stock logo
IRIX
IRIDEX
0.55
1.54
0.85
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
16.42
15.89
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.21
2.05
1.60

Institutional Ownership

CompanyInstitutional Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
65.06%
IRIDEX Co. stock logo
IRIX
IRIDEX
20.10%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%

Insider Ownership

CompanyInsider Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.60%
IRIDEX Co. stock logo
IRIX
IRIDEX
7.30%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
24.00%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
33.51%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nuwellis, Inc. stock logo
CHFS
Nuwellis
666.04 millionN/ANot Optionable
IRIDEX Co. stock logo
IRIX
IRIDEX
12016.79 million15.42 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million10.11 millionNot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
4603.21 million2.14 millionNot Optionable

Recent News About These Companies

Star Equity Q4 EPS Lowered by Litchfield Hills Research

New MarketBeat Followers Over Time

Media Sentiment Over Time

Nuwellis stock logo

Nuwellis NASDAQ:CHFS

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$0.98 -0.02 (-1.54%)
As of 05/23/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.23 +0.02 (+1.65%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.24 +0.01 (+0.81%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Star Equity stock logo

Star Equity NASDAQ:STRR

$2.00 -0.06 (-2.91%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$2.04 +0.04 (+2.25%)
As of 05/23/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.